I am a surgeon with expertise in minimally invasive techniques for the treatment of urologic malignancies, including prostate cancer and kidney tumors. I have advanced skills in MRI image-guided procedures for the diagnosis and treatment of prostate cancer. I have a special interest in actively monitoring prostate cancer patients using state-of-the art imaging technology and in directing organ-sparing approaches for curative therapeutic interventions. I am dedicated to optimizing cure and preserving post-treatment function so patients can enjoy a long and optimal quality of life.
My research interests complement my clinical practice through development of promising new methods to diagnose, evaluate, and treat urologic malignancies. I am the lead investigator for a clinical trial evaluating MRI-guided focal therapy for prostate cancer. I am actively involved in Memorial Sloan Kettering Cancer Center’s comprehensive active surveillance program for low-risk prostate cancer. My research in this program incorporates biomarkers and advanced imaging to detect cancer progression. My other research interests utilize the SEER-Medicare database to study treatment patterns, complications, and survival in urologic malignancies to better inform patients and improve clinical decision-making.
My philosophy is focused on service to patients and families and to integrated treatment plans tailored to each patient’s values.
I am fluent in English and Farsi.